Analyst Ratings for Edgewise Therapeutics (EWTX)
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $51.00 (Piper Sandler)
- Lowest: $20.00 (Goldman Sachs)
- Average: $39.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.10 (+40.5%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 82%
Avg. $ Target:
$39.10 (+40.5%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2025 | Goldman Sachs | Paul Choi | New Coverage | Neutral (N/A) |
20.00 (N/A) |
15.09 (27.82) |
84.36% | Details |
| 7/30/2025 | Raymond James » Updated 2/26/2026 |
Martin Auster | New Coverage | Strong Buy (N/A) |
46.00 (N/A) |
14.26 (27.82) |
95.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
